Authors: Lenz, J Su, M Mizrachi, Y Burke, M Rubinstein, A

Citation: J. Lenz et al., V3 variation in HIV-seropositive patients receiving a V3-targeted vaccine, AIDS, 15(5), 2001, pp. 577-581

Authors: Fahey, JL Aziz, N Spritzler, J Plaeger, S Nishanian, P Lathey, JL Seigel, J Landay, AL Kilarui, R Schmitz, JL White, C Wara, DW Akridge, R Cutili, J Douglas, SD Reuben, J Shearer, WT Nokta, M Polland, R Schooley, R Asthana, D Mizrachi, Y Waxdal, M

Citation: Jl. Fahey et al., Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation, CL DIAG LAB, 7(4), 2000, pp. 540-548

Authors: Rubinstein, A Mizrachi, Y Bernstein, L Shliozberg, J Golodner, M Liu, GQ Ochs, HD

Citation: A. Rubinstein et al., Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage Phi X174 in asymptomatic HIV-1 infected patients, AIDS, 14(4), 2000, pp. F55-F62

Authors: Rubinstein, A Mizrachi, Y Pettoello-Mantovani, M Lenz, J Liu, GQ Rubinstein, Y Goldstein, H Yust, I Burke, M Vardinon, N Spirer, Z Cryz, SJ

Citation: A. Rubinstein et al., Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates, J ACQ IMM D, 22(5), 1999, pp. 467-476

Authors: Aveni, A Mizrachi, Y

Citation: A. Aveni et Y. Mizrachi, The geometry and astronomy of Rujm el-Hiri, a megalithic site in the Southern Levant, J FIELD ARC, 25(4), 1998, pp. 475-496